2023 ASH｜中国研究最全汇总，看这一篇就够了！|diagnosed|newly|patients|results|treatment|with|中国研究|华西医院

前言

一年一度的美国血液学会（ASH）年会是全球血液学领域最受瞩目的国际学术盛会之一，每年都吸引着来自世界各地的专家学者。2023年第65届ASH年会将于12月9日-12日在美国圣迭戈召开，会议将公布最顶尖的血液学领域研究摘要，探讨如何改善患者的管理和治疗、探寻新的治疗方案。

近年来，中国临床研究发展迅速，中国在世界血液学领域的影响力也日益增加。作为中国疫情政策开放后的第一届ASH年会，相信今年我国会有更多的专家学者踏上ASH年会的舞台，分享他们的研究成果、观点和经验。

根据当地时间11月2日上午9:00 ASH官网公布的摘要，今年我国专家共有64篇研究入选Oral Abstracts ，466篇研究入选Poster Abstracts，相比去年增长47%！特将研究相关信息整理如下，以飨读者。

Oral Abstracts

摘要号标题/报告人及单位7Bromodomain Protein BRD4 Is a Transcriptional Repressor of Terminal Erythropoiesis By Interacting with EHMT1/2
Meng Zhang，浙江大学医学院附属第一医院
10A Mediator Switch Tunes Transcription Pausing to Drive Erythropoiesis
Hsiang-Ying Lee，北京大学
55Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study
杨莉，上海交通大学医学院附属同仁医院
83Loss of DDX3X Function Promotes CLL Progression By Facilitating NOTCH1 mRNA Translation
苗毅，江苏省人民医院
101A Multi-Omic Single-Cell Landscape of Cytokine Release Syndrome in Multiple Myeloma Patients after Anti-BCMA CAR-T Cell Therapy
胡永仙，浙江大学医学院附属第一医院
117Discovery of BCL-XL Heterobifunctional Degrader with Potentially Improved Therapeutic Window and Minimal Platelet Toxicity for Hematological Malignancies
Yang Xie，北京星亢原生物科技有限公司
123Development and Validation of Deep Learning Model for Diagnosis and Subtypes Differentiation of Myeloproliferative Neoplasms Using Clinical Data and Digital Pathology
Zhongxun Shi，江苏省人民医院
139Mitochondrial tRNA Pseudouridylation Regulates Erythropoiesis Via the mTOR Signaling Pathway: Implications for Mlasa and Treatment Strategies
Yajing Chu，中国医学科学院血液病医院（中国医学科学院血液学研究所）
142The ATF4-RPS19BP1 Axis Modulates Ribosome Biogenesis to Promote Erythropoiesis
Zhaofeng Zheng，中国医学科学院血液病医院（中国医学科学院血液学研究所）
157An Entirely Oral Regimen of Oral-Arsenic Trioxide/All-Trans Retinoic Acid/Ascorbic Acid in Newly-Diagnosed Acute Promyelocytic Leukaemia (APL): Updated Results of an Ongoing Multicentre Trial
Harinder Gill，香港大学
188Clinical Implications of CSF-Ctdna in CNS Involvement of Newly Diagnosed Diffuse Large B Cell Lymphoma: An Improvement of Diagnosis, Treatment and Evaluation
梁金花，江苏省人民医院
189Diagnostic and Prognostic Value of Circulating Cell-Free DNA in Cerebrospinal Fluid and Plasma in Newly Diagnosed Diffuse Large B Cell Lymphoma
李炳宗，苏州大学附属第二医院
218Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial
陆佩华，北京陆道培医院
234Short-Term Blinatumomab As a Bridge Therapy for Hematopoietic Stem Cell Transplantation in B-Cell Acute Lymphoblastic Leukemia with Low Leukemia Burden
Hang Zhang，四川大学华西医院
239CD7 Chimeric Antigen Receptor T-Cell Therapy Bridging to Allogeneic Hematopoietic Stem Cell Transplantation Remarkably Improved Long-Term Disease-Free Survival in Refractory/Relapsed T-Cell Acute Lymphoblastic Leukemia/Lymphoma
李智慧，北京高博博仁医院
278Gpibα Caar-T Cells Induce Autoreactive B Cells Elimination to Treat Immune Thrombocytopenia
梅恒，华中科技大学同济医学院附属协和医院
279Iguratimod Regulates CD4+ T-Cell Homeostasis and Function By Restoring PINK1/Parkin-Mediated Mitophagy in Immune Thrombocytopenia
Yuxiu Chen，北京大学人民医院
281Notch1 Regulates Hepatic Thrombopoietin Production
乔建林，徐州医科大学
286The Impacts of Genetic Polymorphisms on the Von Willebrand Factor Level in Type 1 Von Willebrand Disease
Yeu-Chin Chen，台湾三军总医院
289CD74+ Leukemia-Associated Macrophages Supporess T Cell Immune Surveillance and Promote Leukemic Cell Growth in Acute Myeloid Leukemia
Guo Qiu，南方医科大学南方医院
304A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma
洪煌明，四川省肿瘤医院
305Golidocitinib in Treating Refractory or Relapsed Peripheral T- Cell Lymphoma: Full Analysis of the Multinational Pivotal Study Results (JACKPOT8)
宋玉琴，北京大学肿瘤医院
306A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas
宋玉琴，北京大学肿瘤医院
320Preliminary Results of a Phase 2 Study of IMM01 Combined with Azacitidine (AZA) As the First-Line Treatment in Adult Patients with Higher Risk Myelodysplastic Syndromes (MDS)
杨威，中国医科大学附属盛京医院
366Deciphering the Impact of Donor Telomere Length on Allogeneic Transplantation Outcomes: Telomere Length Matters More Than Age
Hengwei Wu，浙江大学医学院附属第一医院
410Targeting G3BP2 Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment Via ELF1-MCL1 Axis
陈智香，福建医科大学附属协和医院
471Mega-Dose Decitabine Intensified Regimen Is More Effective at Eliminating Pre-HSCT Measurable Residual Disease Compared to the Bu/Cy Regimen: A Multicenter Prospective Phase II Study
Hao Zheng，北京大学人民医院
474The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML
Xiaoyu Zhang，中国医学科学院血液病医院（中国医学科学院血液学研究所）
476Clonal GZMK+CD8+ t Cells Are Identified As a Hallmark of Pathogenesis of Cgvhd-Induced Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation
肖浩文，浙江大学医学院附属邵逸夫医院
480SLC16A7 Facilitates aGVHD through Regulating Calcium Influx and Lipid Metabolism of CD4+ T Cells
Xiaoxuan Lai，苏州大学附属第一医院
524CD58 Genetic Alterations and Its Contribution to Upregulation of PD-L1 and IDO Via LYN/CD22/SHP1 Axis in DLBCL
Xiyue Xu，天津医科大学肿瘤医院
572KP104, a Bifunctional C5 Antibody/Factor H Fusion Protein, Effectively Controls Both Intravascular and Extravascular Hemolysis: Interim Results from a Phase 2 Study in Complement Inhibitor-Naïve PNH Patients
张凤奎，中国医学科学院血液病医院（中国医学科学院血液学研究所）
586IL1RAP-Specific T Cell Engager (TCE) Antibody Efficiently Depletes Acute Myeloid Leukemia (AML) Leukemic Stem Cells (LSCs)
张仪，浙江大学医学院附属第一医院
609IMM01 Plus Tislelizumab in Prior Anti-PD-1 Failed Classic Hodgkin Lymphoma: An Open Label, Multicenter, Phase 2 Study (IMM01-04) Evaluating Safety As Well As Preliminary Anti-Tumor Activity
周可树，河南省肿瘤医院
621Phase 2 Study to Assess the Safety and Efficacy of Bomedemstat (MK3543) in Combination with Ruxolitinib in Patients with Myelofibrosis
Harinder Gill，香港大学
627HMR Mutations Drive Poor Prognosis in Myelofibrosis Patients with Lower JAK2V617F Allele Burden but Not in Those with Higher Allele Burden: Results of a Multicenter Study
Yu-Hung Wang，国立台湾大学医学院
650Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Identical Peripheral Blood Hematopoietic Stem Cell Transplantation
Hang Zhang，四川大学华西医院
659Comparative Study for Haplo, MSD and MUD Allo-Hcts for Core-Binding Factor AML Patients in CR2: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
叶逸山，浙江大学医学院附属第一医院
660Comparative Study for Haplo, MSD and MUD Allo-Hcts for AML Patients with KMT2A Rearrangement: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
叶逸山，浙江大学医学院附属第一医院
686Integrin αvβ8-Mediated Activation of TGF-β1 Is Involved in Regulating the Sustained Response after TPO-Ras Withdrawal in ITP Patients
Min Xu，华中科技大学同济医学院附属协和医院
687Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial
Xu Yanmei，中国医学科学院血液病医院（中国医学科学院血液学研究所）
688The Therapeutic Efficacy of CD19 Chimeric Antigen Receptor T Cells in Immune Thrombocytopenia Model
Yun Wang，山东大学齐鲁医院
729Outcomes of Children and Adolescents with Acute Myeloid Leukemia Given a Low-Versus Standard-Dose Chemotherapy Regimen for Remission Induction (CALSIII-AML18): A Multicenter, Phase 3, Randomized, Noninferiority Trial
Li Gao，苏州大学附属儿童医院
736A Prospective Multicenter Phase II Study of Orelabrutinib-Lenalidomide-Rituximab (OLR) in Patients with Untreated Mantle Cell Lymphoma (MCL) in China (POLARIS Study): Preliminary Analysis on Efficacy, Safety, Mutation Spectrum and Impact of Mutation Profiling on Treatment Responses
张会来，天津医科大学肿瘤医院
761Efficacy Outcomes and Characteristics of Patients with Multiple Myeloma (MM) Who Achieved Sustained Minimal Residual Disease Negativity after Treatment with Equecabtagene Autoleucel (Eque-cel, CT103A) in Fumanba-1
李春蕊，华中科技大学同济医学院附属同济医院
778Safety and Efficacy of Human Amniotic Epithelial Stem Cells Eye Dropin Ocular Chronic Graft-Versus-Host Disease
Xianjing Cheng，陆军军医大学第二附属医院（新桥医院）
803Prednisone Plus Ivig Compared with Prednisone for Immune Thrombocytopenia during Pregnancy
Yuxiu Chen，北京大学人民医院
827Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study
弓晓媛，中国医学科学院血液病医院（中国医学科学院血液学研究所）
829Optimization of Idarubicin and Cytarabine Induction Regimen with Homoharringtonine for Newly Diagnosed AML Based on the Peripheral Blast Clearance Rate: First Result of the Multicenter, Randomized, Phase 3 Trial (RJ-AML 2016)
Yunxiang Zhang，上海交通大学医学院附属瑞金医院
834Venetoclax Plus Azacitidine, Low Dose Cytarabine, Aclarubicin and G-CSF (VA-CAG Regimen) for Newly Diagnosed Young Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase 2 Clinical Trial
Xiaoping Li，中国人民解放军联勤保障部队第九二〇医院
846Clonal Evolution Dissection Reveals High MSI2 Level Promotes Chemo-Resistance in T-Cell Acute Lymphoblastic Leukemia
Jingliao Zhang，中国医学科学院血液病医院（中国医学科学院血液学研究所）
857A Phase II Study of the Efficacy and Safety of the Srmt (Sintilimab, Rituximab, Methotrexate, and Temozolomide) Regimen in Newly Diagnosed Primary Central Nervous System Lymphoma
曾志勇，福建医科大学附属第一医院
867Safety and Efficacy of Tgrx-678, a Potent BCR-ABL Allosteric Inhibitor in Patients with Tyrosine Kinase Inhibitor (TKI) Resistant/Refractory Chronic Myeloid Leukemia (CML): Preliminary Results of Phase I Study
江倩，北京大学人民医院
869Olverembatinib (HQP1351) Demonstrates Efficacy Vs. Best Available Therapy (BAT) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic Myeloid Leukemia Chronic-Phase (CML-CP) in a Registrational Randomized Phase 2 Study
江倩，北京大学人民医院
879The Specific Transcriptional Signature and Clonal Selection of MGUS-like Profile Predict an Exceptionally Favorable Prognosis in Patients with Newly-Diagnosed Multiple Myeloma
Wenqiang Yan，中国医学科学院血液病医院（中国医学科学院血液学研究所）
889Efficacy and Safety of Interleukin-6-Knockdown CD19-Targeted CAR T Cells(ssCART-19) for Relapsed/Refractory B-ALL
Lei Yu，上海优卡迪生物医药科技有限公司
891Dasatinib and CAR-T Cell Therapy for Newly Diagnosed Ph-Positive Acute Lymphoblastic Leukemia in Adults
Mingming Zhang，浙江大学医学院附属第一医院
969Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial
索晓慧，邯郸市中心医院
970Comparing the Efficacy and Safety of Venetoclax Combined with Decitabine Versus Conventional Chemotherapy As Induction Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia - Interim Analysis of a Multicenter, Randomized, Phase 2b Trial
卢静，苏州大学附属第一医院
1022Updated Results of a Phase I Open-Label Single-Arm Study of Dual Targeting BCMA and CD19 Fastcar-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma
杜鹃，上海长征医院
1025C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up
梁爱斌，上海市同济医院（同济大学附属同济医院）
1037Manufacturing of a Subsequent Autologous CAR-T Product after Prior CAR-T Is Safe and Feasible
Yi-Jiun Su，台湾林口长庚医院
1039Neither Conditioning Chemotherapy Nor GvHD-Prophylaxis: CD7 CAR-T Treatment Bridging to Haplo-HSCT
胡永仙，浙江大学医学院附属第一医院
1041Haploidentical Hematopoietic Cell Transplantation Combined with an Unrelated Cord Blood Unit for Adult Acute Myeloid Leukemia Results in Improved Survival Compared to Haploidentical Hematopoietic Cell Transplantation: Results of a Multicenter, Randomized, Phase III Trial
Biqi Zhou，苏州大学附属第一医院

Poster Abstracts

要号标题/报告人及单位1165Clinical Characteristics, Genomic Profiling and Outcomes of Langerhans Cell Histiocytosis in Adults with Single System Multifocal Disease
Hong-Xiao Han，北京协和医院
1167Myelodysplastic Syndrome Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Study of 15 Cases in a Single Center
Yue Song，苏州大学附属第一医院
1175Caebv Disease Originates from Infected Hematopoietic Stem Cells
王晶石，首都医科大学附属北京友谊医院
1176A Respective Analysis of EBV DNA Status in T/NK Cell Lymphoma Associated-Hemophagocytic Lymphohistiocytosis
Lulu Wang，浙江大学医学院附属第一医院
1181Virus-Specific CD8+ Stem Memory T Lymphocytes Display Enhanced Anti-Virus Responses
Xunhong Cao，北京大学人民医院
1185Pgam1 Regulate Adaptive NK Cells in Anti-Viral and Anti-Tumor Response
Juan Xie，北京大学人民医院
1205N-Acetylneuraminic Acid Induces Vascular Endothelial Dysfunction through Targeting Mcu/SQSTM1 Pathway and Attenuates Atherosclerosis
Limei MA，重庆医科大学
1206CM313, a Novel Anti-CD38 Antibody, As a Potential Treatment for Primary Immune Thrombocytopenia: A Phase II Trial
Yunfei Chen，中国医学科学院血液病医院（中国医学科学院血液学研究所）
1207Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
赵芃，北京大学人民医院
1213The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy
Yun He，北京大学人民医院
1216Effect of Hetrombopag Combined with Rhtpo in Patients with Severe Immune Thrombocytopenia
殷杰，苏州大学附属第一医院
1217Eltrombopag Plus Rhtpo for Corticosteroid-Resistant or Relapsed ITP: A Prospective Observed Study
付海霞，北京大学人民医院
1219The Role of Gpiba in Control of Megakaryocyte Reactivity to Thrombopoietin
Fengjiao Han，山东大学齐鲁医院
1229Discovery of BT-114143, a Novel and Potent Small-Molecule Plasminogen Inhibitor for Hyperfibrinolysis
唐军，赛诺哈勃药业(成都)有限公司
1233Thrombosis Caused By a Novel Coagulation Factor IX Mutation (FIX Shanghai II)
Wenman WU，上海交通大学医学院附属瑞金医院
1236Proteomics Reveals the Potential Pathogenesis of Coagulopathy in Patients with Hematological Malignancies Following CAR-T Therapy
Yingying Li，华中科技大学同济医学院附属协和医院
1268The Proactive Diagnostic Value of Thrombin-Antithrombin Complex and Antithrombin III in Disseminated Intravascular Coagulation
Qiuyu Guo，山东大学齐鲁医院
1278Risk Factors of Venous Thromboembolism in Lymphoma Patients: A Meta-Analysis
Cuiting Jiang，重庆大学附属肿瘤医院
1305Unrevealing Hematopoietic Reconstruction Discrepancies after Allo-UCBT and Allo-PBSCT at Single Cell Resolution
Qing Li，中国医学科学院血液病医院（中国医学科学院血液学研究所）
1313Nynrin Preserves Hematopoietic Stem Cell Function Via the Ppif-Mediated Mitochondrial Permeability Transition
周成芳，重庆医科大学生命科学研究院
1316The Relationship between Telomere Length and Epigenetic Aging with Hematologic Diseases Risk: A Multivariable Mendelian Randomisation Study
Yang Li，中国医学科学院血液病医院（中国医学科学院血液学研究所）
1343The Efficacy of Hetrombopag Combined with Cyclosporine a in Patients with Transfusion-Dependent Non-Severe Aplastic Anemia
何广胜，江苏省人民医院
1345Efficacy, Safety, and Population Pharmacokinetics of Eltrombopag in Children with Different Severities of Aplastic Anemia
Wei Zhang，山东大学齐鲁医学院
1348Efficacy and Safety of Recombinant Thrombopoietin Combined with Immunosuppressive Therapy for Primary Treatment of Severe Aplastic Anemia: A Single-Center, Open-Label, Randomized, Clinical Trial
Wenrui Yang，中国医学科学院血液病医院（中国医学科学院血液学研究所）
1350The Change of Complement Deposition after Complement Inhibitor Treatment in Paroxysmal Nocturnal Hemoglobinuria Patients
Menglu Zhang，北京协和医院
1351A Preliminary Report of Clinical Study on Immunosuppressive Therapy Combined with Avatrombopag As the First-Line Treatment for Severe Aplastic Anaemia in Elderly Patients
Lei Ye，中国医学科学院血液病医院（中国医学科学院血液学研究所）
1353Clinical Features and Outcomes in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia with STAT3 Mutation
Xiaoqing Liu，南京中医药大学附属南京医院
1366Clinical Features and Monitoring of Germline CEBPA-Mutated Carriers
潘莉莉，福建医科大学附属协和医院
1367Phase Separation of PML/RARa Microspeckles Governs Transcriptional Dysregulation through Genomic Rewiring of BRD4 in Acute Promyelocytic Leukemia
Yi Zhang，上海交通大学医学院附属瑞金医院
1372Kdm6a Modulates Hematopoiesis and Leukemogenesis Via Demethylase-Dependent Epigenetic Programming
Huiqiao Chen，浙江大学医学院附属邵逸夫医院
1373PGK1 Represents a Therapeutic Target for Pediatric Acute Myeloid Leukemia Via Regulating c-Myc/SLC7A5/mTOR Pathway
Yijun Wu，苏州大学附属儿童医院
1379Ebf1 Is Involved in Primitive Myelopoiesis and Contributes in Leukemia Pathogenesis
Rongtao Xue，南方医科大学南方医院
1414Partner Gene Associated Trinary Fusion and Orchestration of Multiple Molecular Events in Acute Promyelocytic Leukemia with Variant Rara Fusion Genes
陈佳琦，北京陆道培医院
1432Modulating Metabolic Reprogramming By Phosphoglycerate Dehydrogenase (PHGDH) Inhibitors in Omipalisib-Refractory AML
Chi-Yang Tseng，国立台湾大学
1442Dynamic Single-Cell Profiling Reveals Novel Immune Regulatory Mechanism of ITK Inhibitor Soquelitinib in Refractory T Cell Lymphoma
丁宁，北京大学肿瘤医院
1462The Different Impacts of an MRD-Guided Protocol on Relapse of Childhood Acute Lymphoblastic Leukemia: The Report of Taiwan Pediatric Oncology Group (TPOG)-ALL-2013
Hsi-Che Liu, MD，马偕纪念医院
1466The Pediatric-Inspired Regimen Improved Quality and Quantity of Life for Patients with Acute Lymphoblastic Leukemia，Beyond Age, Risk Stratification, and Hematopoietic Stem Cell Transplantation
Junjie Chen，南方医科大学南方医院
1481Cytoreductive Chemotherapy in Induction Therapy Plays a Key Role in the Prognosis of Patients with Low-Risk Acute Promyelocytic Leukemia
Xiaolu Zhu，北京大学人民医院
1485Identification of Characteristics and Prognostic Impact of FUS-ERG and AML1-MTG16 Fusion Genes in Adult AML Patients
Ziyue Zhou，浙江大学医学院第一附属医院
1501Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial
薛胜利，苏州大学附属第一医院
1504Frontline Combination of 3rd Generation TKI Olverembatinib and Blinatumomab for Ph+/Ph-like ALL Patients
Ting Zhang，zhangtashley@hotmail.com, Guangzhou, China
1505Efficacy and Safety of Avatrombopag in the Treatment of Chemotherapy-Induced Thrombocytopenia in Children with Acute Lymphoblastic Leukemia: A Retrospective Study
Libai Chen，南方医科大学南方医院
1506Venetoclax, Cladribine and Cytarabine for the Treatment of Relapse/Refractory Acute Lymphoblastic Leukemia: Interim Analysis of a Phase 2 Trial
薛胜利，苏州大学附属第一医院
1517Venetoclax Combined with Homoharringtonine,Cytarabine and Aclacinomycin (HAAV) As Induction Therapy in Newly Diagnosed Young Adult Acute Myeloid Leukemia
周泽平，昆明医科大学第二附属医院
1518Venetoclax Combined with Hypomethylation Agents As Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia - Priliminary Results from a Real World Study in China
戴海萍，苏州大学附属第一医院
1522ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the "3+7" Regimen in Newly Diagnosed AML: A Real-World Experience from South China
翁建宇，广东省人民医院
1524Cladribine Combined with Homoharringtonine and Cytarabine Achieves a High Remission Rate in Adult Patients with De Novo Acute Myeloid Leukemia, Especially for Adverse-Risk Group: A Prospective, Single Center, Single-Arm, Phase 2 Study
孙杰，浙江大学医学院附属第一医院
1525Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Wen-Jing Yu, 北京大学人民医院
1527Idarubicin Plus Azacitidine + Venetoclax As Induction Therapy Achieved High Remission in Elderly Fit- Acute Myeloid Leukemia Patients: Preliminary Results of a Phase II Study
Xinjie Chen，上海交通大学医学院附属瑞金医院
1528Improved Prevention and Treatment Strategy of Differentiation Syndrome Contribute to Reduce Early Death of Patients with Acute Promyelocytic Leukemia
Qian Wu，苏州大学附属第一医院
1530Sorafenib Plus Triplet Therapy with Venetoclax, Azacitibine and Homoharringtonine for Refractory/Relapsed Acute Myeloid Leukemia with FLT3-ITD: A Multicentre, Phase 2 Study
Sijian Yu，南方医科大学南方医院
1561Role of ITGA5 in Malignant Proliferation and Infiltration of Acute Myeloid Leukemia
Xinqi Li，武汉大学中南医院
1566Advances in Acute Myeloid Leukemia Classification: A Comparative Analysis of Who-HAEM4R, Who-HAEM5, and International Consensus Classification
陈雪，北京陆道培医院
1568Heterogeneity and Differentiation Patterns of pDC Cells in pDC-AML: A Novel Perspective from Single-Cell RNA Sequencing
Xingcheng Yang，华中科技大学同济医学院附属同济医院
1576The Ingenious Multiple Efficacies of the Integrated Gene Fragment of Torque Teno Mini Virus in Orchestrating Promyelocytic Leukemogenesis Via Hijacking Rara
周晓苏，北京陆道培医院
1578Targeting HDAC9 Contributes to Degradation of MLL Fusion Oncoproteins in KMT2A-Rearranged Acute Myeloid Leukemia
Yutong Zhou，浙江大学医学院附属第一医院
1592PET Tracer-Based Glucose Uptake Predicts Clinical Response to Induction Therapy in Acute Myeloid Leukaemia
曾辉，暨南大学附属第一医院
1607One Tube 23 Color Full Spectral Flow Cytometry Panel in Detecting Minimal Residual Disease in Pediatric B-Cell Acute Lymphoblastic Leukemia
Kefei Wu，上海交通大学医学院附属上海儿童医学中心
1610Deciphering the Structural Variants in B Cell Acute Lymphoblastic Leukemia By Optical Genome Mapping
刘铭，北京陆道培医院
1611CD38 Is a Functional Partner of CD9 in B-Cell Precursor Acute Lymphoblastic Leukemia
Po Yee Chung，香港中文大学儿科学系
1612Clinical Implications of Germline Predisposition Gene Variants in Patients with Refractory or Relapsed B Acute Lymphoblastic Leukemia
Zhao Defeng，北京高博博仁医院
1628Extrachromosomal Circular DNA Drives the Progression of DLBCL through Activating the Sting Pathway
Zijuan Wu，江苏省人民医院
1634Targeting the Cgas-Sting Pathway Inhibits the Progression and Enhances the Chemotherapy Efficacy of Peripheral T-Cell Lymphoma